CoreAge Rx™ Compounded Tirzepatide (Flat $129/mo)
Clinical trials reveal Tirzepatide patients lose up to 22.5% of total body weight—outperforming single-target semaglutide by 50%. CoreAge Rx delivers pure compounded Tirzepatide across ALL dosages (2.5mg up to 15mg) at a flat $129/month without retail drug shortages or thousand-dollar markups.
- $0 Online Physician Assessment & Prescription
- Formulated in Licensed 503A Sterile Compounding US Pharmacy
- All Medication & Administration Supplies Included
- Free Discreet Express Overnight Temperature-Controlled Shipping
Clinical Telehealth Case Study
""
The GIP + GLP-1 Synergy: Why Dual Agonism Outperforms Single-Target Therapy
Tirzepatide represents the premier breakthrough in peptide endocrinology. While semaglutide acts solely on the GLP-1 receptor, Tirzepatide is a single synthetic peptide with dual agonism at both Glucose-Dependent Insulinotropic Polypeptide (GIP) and GLP-1 receptors.
In human biology, GIP and GLP-1 work synergistically. GIP receptors are densely populated in subcutaneous and visceral adipose tissue. Stimulating GIP receptors enhances insulin sensitivity in adipocytes, optimizes lipid clearance, increases blood flow to white adipose tissue, and amplifies the brain's satiety response beyond what GLP-1 can achieve alone.
In the landmark SURMOUNT-1 clinical trial published in the New England Journal of Medicine, participants on maximum dose Tirzepatide achieved an unprecedented average weight reduction of 22.5% (an average of 52 pounds), with nearly 40% of patients losing over a quarter of their entire body weight.
Tirzepatide vs. Semaglutide vs. Commercial Brands
Compare biological mechanisms, clinical efficacy, and monthly costs.
| Clinical Metric | RECOMMENDED CoreAge Rx™ Tirzepatide | Retail Zepbound®/Mounjaro® | Compounded Semaglutide |
|---|---|---|---|
| Receptor Target Mechanism | ✓ Dual GIP + GLP-1 Receptor Agonist | ✓ Dual GIP + GLP-1 Receptor Agonist | ⚠️ Single GLP-1 Receptor Agonist only |
| Clinical Weight Loss Percentage | ✓ Up to 22.5% average body weight loss | ✓ Up to 22.5% average body weight loss | ⚠️ Up to 14.9% average body weight loss |
| Monthly Cost at 10mg - 15mg Doses | ✓ Flat $129 / month (No dose escalators) | ✗ $1,050 to $1,350+ out of pocket | ✓ $79 / month flat |
| Insurance Authorization Required | ✓ None — Cash-pay transparent pricing | ✗ 90%+ denial rate for obesity diagnosis | ✓ None — Direct patient access |
| Supply Chain & Backorder Status | ✓ Steady production in US 503A cleanrooms | ✗ Frequent nationwide pharmacy stockouts | ✓ High stability & availability |
Everything Included In Your Prescription
Zero hidden membership fees. Zero dosage price escalators.
Patient Reviews & Verified Outcomes
Real experiences from patients prescribed this telehealth protocol.
""Tirzepatide broke right through my stubborn plateau""
"I stalled on regular semaglutide after 15 lbs. Switching to Tirzepatide was like stepping on the gas pedal. The dual action completely wiped out my evening snacking, and I've dropped 54 lbs total."
""The flat $129 price is unbeatable""
"My local medspa wanted $650 a month for 10mg Tirzepatide. CoreAge Rx gives me the exact same sterile 503A compounded medication for $129. Unbelievable savings and top-tier service."
""No brain fog, no hunger, just steady fat loss""
"I feel energetic throughout the day, my fasting blood glucose dropped from 118 to 86, and I've lost over 40 pounds. The shipping is fast, reliable, and completely discreet."
""Super smooth delivery and great doctor support""
"I was nervous about compounding, but the quality is immaculate. Arrives perfectly cold in insulated packaging with clear instructions. It has transformed my relationship with food."
Frequently Asked Clinical & Telehealth Questions
Everything you need to know about physician consultations, sterile compounding safety, pricing, delivery, and guarantees.
Why is Tirzepatide considered more potent than Semaglutide?
Semaglutide is a single receptor agonist acting only on GLP-1. Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors. GIP enhances insulin sensitivity directly in fat cells and synergistically amplifies the brain's satiety signals. In clinical trials, Tirzepatide produced up to 22.5% average weight reduction compared to roughly 15% for Semaglutide.
Will my price increase when I titrate from 2.5mg to 15mg?
No! CoreAge Rx is committed to transparent flat-rate pricing. Whether you are on the 2.5mg starting dose or the maximum 15mg maintenance dose, your monthly price remains locked at $129. We do not use dosage escalators or penalize patients for progressing in their treatment.
Is compounded Tirzepatide identical to commercial Zepbound or Mounjaro?
Compounded Tirzepatide contains the same active pharmaceutical ingredient (Tirzepatide base) formulated by state-licensed 503A compounding pharmacies pursuant to individual patient prescriptions. It is dispensed in multi-dose glass vials rather than proprietary pre-filled single-dose auto-injector pens, avoiding manufacturer patent markups and supply chain shortages.
How quickly will I start noticing appetite suppression on Tirzepatide?
Most patients report a substantial reduction in cravings and 'food noise' within 24 to 48 hours following their first subcutaneous injection. Measurable weight reduction typically begins within the first week as glycogen water weight releases, followed by steady adipose fat burning.
What happens if the medical provider determines I am not a candidate?
Patient safety is our primary directive. If our licensed physician reviews your medical questionnaire and determines Tirzepatide is clinically contraindicated for you, your transaction will be cancelled and 100% of your funds will be promptly refunded.
Experience The Dual-Action Tirzepatide Breakthrough Today
Stop settling for single-receptor therapies or thousand-dollar retail bills. Lock in flat $129/month Tirzepatide across all doses with full physician consultation included.